50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
The 3-Stock Retirement Blueprint (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
The 3-Stock Retirement Blueprint (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
The 3-Stock Retirement Blueprint (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
The 3-Stock Retirement Blueprint (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
The 3-Stock Retirement Blueprint (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
The 3-Stock Retirement Blueprint (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
The 3-Stock Retirement Blueprint (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
The 3-Stock Retirement Blueprint (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
NASDAQ:AMGN

Amgen - AMGN SEC Filings & 10K Form

$225.99
-0.88 (-0.39%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$225.02
▼
$229.96
50-Day Range
$224.46
▼
$253.15
52-Week Range
$198.64
▼
$258.45
Volume
2.00 million shs
Average Volume
3.04 million shs
Market Capitalization
$120.89 billion
P/E Ratio
19.15
Dividend Yield
3.42%
Price Target
$242.64

Recent Amgen SEC Filings

Export to Excel
DateFilerForm TypeView
08/23/2022
4:37 PM		Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2022
8:03 PM		Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
5:16 PM		Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
3:10 PM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2022
4:20 PM		Amgen (Filer)
Form 424B2
08/15/2022
5:06 PM		Amgen (Subject)
Form FWP
08/15/2022
7:48 AM		Amgen (Filer)
Form 424B3
08/12/2022
4:38 PM		Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2022
4:40 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2022
4:39 PM		Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2022
4:38 PM		Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2022
3:37 PM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2022
7:08 AM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2022
8:45 PM		Amgen (Issuer)
Drake Michael V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2022
8:24 PM		Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2022
8:22 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2022
8:19 PM		Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:58 PM		Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:57 PM		Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:56 PM		Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:56 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:55 PM		Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:54 PM		Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:54 PM		Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:53 PM		Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:52 PM		Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:52 PM		Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
8:51 PM		Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2022
3:23 PM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
6:45 PM		Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:14 PM		Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:12 PM		Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:10 PM		Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:09 PM		Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:08 PM		Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:07 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:05 PM		Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:03 PM		Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:02 PM		Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
6:00 PM		Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
7:10 PM		Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
7:07 PM		Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
7:05 PM		Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
7:02 PM		Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
7:00 PM		Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:57 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:54 PM		Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:51 PM		Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:48 PM		Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:44 PM		Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:40 PM		Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2022
6:37 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:49 PM		Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:47 PM		Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:45 PM		Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:44 PM		Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:43 PM		Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:41 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:39 PM		Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
5:37 PM		Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
7:45 AM		Amgen (Filer)
Form DEFA14A
04/27/2022
3:19 PM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2022
8:03 AM		Amgen (Filer)
Form DEFA14A
04/13/2022
7:46 AM		Amgen (Filer)
Form DEFA14A
09/13/2021
6:28 PM		Amgen (Issuer)
Khosla Rachna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/13/2021
6:27 PM		Amgen (Reporting)
BeiGene, Ltd. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
6:00 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
5:59 PM		Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
5:56 PM		Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
4:03 PM		Amgen (Filer)
Form 424B2
08/05/2021
7:31 AM		Amgen (Filer)
Form 424B3
07/30/2021
5:14 PM		Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2021
5:08 AM		Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2021
6:22 PM		Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:24 PM		Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:23 PM		Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:22 PM		Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:20 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:19 PM		Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:18 PM		Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:17 PM		Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:15 PM		Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
8:14 PM		Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
7:11 PM		Amgen (Issuer)
SUGAR RONALD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
7:10 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:38 PM		Amgen (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:44 PM		Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:41 PM		Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:38 PM		Amgen (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:35 PM		Amgen (Issuer)
Louie Linda H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:31 PM		Amgen (Issuer)
Johnston Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:21 PM		Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:18 PM		Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:15 PM		Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:12 PM		Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:44 PM		Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:41 PM		Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:38 PM		Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:20 PM		Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2021
7:17 PM		Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:AMGN) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.